The U.S. Department of Health and Human Services Office of the Chief Technology Officer and the American Society of Nephrology have selected 15 winning teams for Phase 1 of the KidneyX Redesign Dialysis prize competition.
During the inaugural KidneyX Summit which began today, April 29th, and continues to through April 30th, the winners were announced. The winners presented their solutions to an audience of industry leaders with government, mechanical and bioengineering, investment, and medical product development.
The prize winners include:
University of Alabama at Birmingham—A non-invasive, wearable telehealth device to detect thrombosis and monitor vascular access health of arteriovenous fistulas and grafts in hemodialysis patients
Qidni Labs, Inc.—Air Removal System for a Wearable Renal Therapy Device
Temple University—Atomically Precise Membranes (APM) for High-Flux and Selective Removal of Blood Toxins
Curion Research Corporation, UCLA and the University of Arkansas— Development of a Dialysate- and Cell-Free Renal Replacement Technology
Outset Medical, Inc.—Development of an Automated Multimodal Sensor to Improve Patient Outcomes in Hemodialysis
Beth Israel Deaconess Medical Center and BioSurfaces, Inc.—Drug-Eluting Electrospun Hemodialysis Graft
Stanford University, Fluo Medical—A non-invasive device for monitoring fistula maturation
Mount Sinai Renal Research Institute—Improving intra-dialytic removal of protein-bound uremic toxin removal using binding competitors
UC San Francisco, Vanderbilt University and Silicon Kidney—Intracorporeal Ultrafiltration System & Intracorporeal Hemodialysis System
Access for Life, Inc. - JEM™—Sensor Enabled Hemodialysis
Miromatrix Medical, Inc.—New Kidney Grafts
University of Michigan—Nitric Oxide-Eluting, Disposable Hemodialysis Catheter Insert to Prevent Infection and Thrombosis
Binnovate Digital Health BV—RenalTracker
University of Washington, Center for Dialysis Innovation—The Ambulatory Kidney to Improve Vitality (AKTIV) & Rethinking Dialysis Vascular Access
Stanford University—Utilizing Optical Interrogation Methods for Early Diagnosis of Peritonitis in Peritoneal Dialysis Patients
“Programs like KidneyX have the potential to improve the lives of millions of people and save billions of dollars in healthcare costs. I’m impressed with the ambitious solutions proposed by the winning teams, and grateful for the entrepreneurs working to reimagine dialysis,” said Ed Simcox, Chief Technology Officer at HHS. “Supporting innovation in this space is a critical step in helping people suffering from kidney diseases.”
Phase 2 of Redesign Dialysis will start accepting submissions in fall 2019 and is open to all, including Phase 1 winners. In Phase 2, innovators will be asked to develop and demonstrate functional and testable prototypes that can replicate some or all kidney functions. Up to three winners will be awarded $500,000 each.